|
PHF2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.39370000008211E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.65249999997774E-06 |
| Normal-vs-Stage2 |
1.836450E-04 |
| Normal-vs-Stage3 |
1.720050E-03 |
| Normal-vs-Stage4 |
5.90299999999599E-05 |
| Stage1-vs-Stage2 |
7.710600E-01 |
| Stage1-vs-Stage3 |
8.683400E-01 |
| Stage1-vs-Stage4 |
3.192400E-01 |
| Stage2-vs-Stage3 |
9.472400E-01 |
| Stage2-vs-Stage4 |
3.178600E-01 |
| Stage3-vs-Stage4 |
3.682200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.9229000005121E-07 |
| Normal-vs-AfricanAmerican |
2.399800E-04 |
| Normal-vs-Asian |
1.021820E-04 |
| Caucasian-vs-AfricanAmerican |
7.186000E-01 |
| Caucasian-vs-Asian |
4.528400E-02 |
| AfricanAmerican-vs-Asian |
3.335700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.37160000030146E-07 |
| Normal-vs-Female |
4.518200E-03 |
| Male-vs-Female |
2.870600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.229580E-04 |
| Normal-vs-Extreme_Weight |
5.68279999999532E-05 |
| Normal-vs-Obese |
9.821200E-03 |
| Normal-vs-Extreme_Obese |
5.66629999999568E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.744600E-01 |
| Normal_Weight-vs-Obese |
1.652350E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.417000E-01 |
| Extreme_Weight-vs-Obese |
2.609800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.034800E-01 |
| Obese-vs-Extreme_Obese |
2.016800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.191700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.122100E-03 |
| Normal-vs-Age(61-80Yrs) |
4.47610004616905E-09 |
| Normal-vs-Age(81-100Yrs) |
3.581700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.023600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.593410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.798010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.842080E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.104400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.457200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.410900E-04 |
| Normal-VS-Type2 PRCC |
3.30370175660732E-11 |
| Normal-VS-KIRP CIMP |
4.548400E-02 |
| Normal-VS-Unclassified PRCC |
6.163400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.05189999999311E-06 |
| Type1 PRCC-VS-KIRP CIMP |
9.697200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.902200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.959690E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.284000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.368800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.81339984431872E-10 |
| Normal-vs-N1 |
1.487850E-02 |
| Normal-vs-N2 |
4.679200E-03 |
| N0-vs-N1 |
1.038760E-01 |
| N0-vs-N2 |
8.661800E-01 |
| N1-vs-N2 |
5.439000E-01 |
|
|
